Aspure Pharma Solutions Private Limited - Company Profile

It is a business services private limited company based in Uppal, Telangana, India, established in 2025.
2025 Uppal, Telangana, India Active
Last Updated:
Access Report
About Aspure Pharma Solutions Private Limited

Aspure Pharma Solutions Private Limited, a active private limited company, was established on 14 January 2025 in Uppal, Telangana, India. it holds CIN: U37003TS2025PTC192871. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ganesh Chadalawada (Additional Director), Kishan Chand Gutta (Director), Buddaiahgari Chandramohan Reddy (Non- Individual Subscriber). It is based at Shed No-56, Phase-2, Sy No-125, Mallapur Vlg, Uppal, Telangana, 500076.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U37003TS2025PTC192871

  • Registration Number

    192871

  • Incorporation Date

    14 January 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 4 Months
Company report

Aspure Pharma Solutions Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Aspure Pharma Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aspure Pharma Solutions Private Limited?
Current Directors
Name Designation Appointment Date Status
Ganesh Chadalawada Additional Director 23 Jan 2025 Current
Kishan Chand Gutta Director 14 Jan 2025 Current
Buddaiahgari Chandramohan Reddy Non- Individual Subscriber 14 Jan 2025 Current
Srilata Talluri Director 14 Jan 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aspure Pharma Solutions.
Aspure Pharma Solutions revenue growth over time
Aspure Pharma Solutions profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aspure Pharma Solutions?

Unlock access to Aspure Pharma Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aspure Pharma Solutions?

Unlock and access historical data on people associated with Aspure Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aspure Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspure Pharma Solutions's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aspure Pharma Solutions
Recent Activity within the Organization
  • Director Appointment

    Ganesh Chadalawada was appointed as a Additional Director was appointed as a Additional Director on 23 Jan 2025 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kishan Chand Gutta was appointed as a Director was appointed as a Director on 14 Jan 2025 & has been associated with this company since 1 year 4 months . was documented.

  • Director Appointment

    Buddaiahgari Chandramohan Reddy was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 14 Jan 2025 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Srilata Talluri was appointed as a Director was appointed as a Director on 14 Jan 2025 & has been associated with this company since 1 year 4 months . was completed.

  • Company Incorporation

    Aspure Pharma Solutions Private Limited was registered on 14 Jan 2025 with Roc Hyderabad & aged 1 year 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aspure Pharma Solutions Private Limited?

The CIN of Aspure Pharma Solutions Private Limited is U37003TS2025PTC192871.

Where is Aspure Pharma Solutions Private Limited headquartered?

Aspure Pharma Solutions Private Limited is headquartered at Shed No-56, Phase-2, Sy No-125, Mallapur Vlg, Uppal, Telangana, 500076.

When was Aspure Pharma Solutions Private Limited incorporated?

Aspure Pharma Solutions Private Limited was incorporated on 14 January 2025.

Who are the current directors of Aspure Pharma Solutions Private Limited?

The current directors of Aspure Pharma Solutions Private Limited are

Is Aspure Pharma Solutions Private Limited a listed company?

Aspure Pharma Solutions Private Limited is unlisted.

What is the capital structure of Aspure Pharma Solutions Private Limited?

The authorized capital of Aspure Pharma Solutions Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available